Pharmaceutical Technology | Drug Development News & Views …
Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
Actuate’s pancreatic cancer therapy gains EMA OMPD
1 day ago · Actuate Therapeutics CEO and president Daniel Schmitt stated: “This regulatory milestone, along with the recently announced positive interim results from our Phase II trial of …
Latest News - Pharmaceutical Technology
Dec 26, 2024 · Eisbach Bio positions HRD-targeting therapy to supplant PARP inhibitors. Eisbach Bio plans to use a $4.75m grant to advance EIS-12656, a small molecule ALC1 inhibitor to …
News - Pharmaceutical Technology
Expanding diagnostic and biomarker options to improve MASH clinical trials. With diagnostics being integral in the detection, confirmation, and monitoring of disease, the lack of adequate …
Pharma breakthroughs: 10 novel drug approvals that made …
Dec 20, 2023 · Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration …
Digital transformation expected to shorten drug development …
Nov 27, 2024 · Commenting on the results Urte Jakimaviciute, senior director of market research and strategic intelligence at GlobalData, said: “Survey findings highlight that the growing …
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
Aug 20, 2024 · Discover how pharmaceutical companies are leveraging AI patents to enhance drug development processes, improve research efficiency, and drive innovation in the industry. …
Pharma companies must adapt to keep pace with AI …
Oct 25, 2024 · Wehrle cautioned this process is not easy. The pharma sector needs to be prepared to adapt to the rapidly changing technology. “We code something and a month later …
Cell and gene therapy approvals drive paradigm change in …
Oct 14, 2024 · From early phase to commercialisation, cell and gene therapies introduce a range of unique challenges – from the complexities of running a patient-centric rare disease trial and …
GSK receives FDA BTD for relapsed osteosarcoma treatment
1 day ago · Conducted by China-based pharmaceutical company Hansoh Pharma, the trial enrolled more than 60 subjects, along with 42 osteosarcoma subjects. GSK oncology research …